Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: A retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group Trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 3, 1998, Pages 653-659

  Prados, Michael D ^a,b   Scott, C B ^a   Rotman, M ^a   Rubin, P ^a   Murray, Kevin ^a   Sause, W ^a   Asbell, S ^a   Comis, R ^a   Curran, W ^a   Nelson, J ^a   Davis, R L ^a   Levin, Victor A ^a   Lamborn, Kathleen ^a   Phillips, Theodore L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Anaplastic astrocytoma; Bromodeoxyuridine; Glioblastoma multiforme; Radiation sensitizer; Radiation therapy

Indexed keywords

BROXURIDINE; CARMUSTINE; CISPLATIN; DACARBAZINE; PREDNISONE; SEMUSTINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; DRUG EFFECT; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIMETABOLITES, ANTINEOPLASTIC; ASTROCYTOMA; BRAIN NEOPLASMS; BROMODEOXYURIDINE; FEMALE; GLIOBLASTOMA; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RADIATION-SENSITIZING AGENTS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 0032005473     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00770-0     Document Type: Article

References (18)

1. 1. Djordjevic, B.; Szblaski, W. Genetics of human cell lines: Incorporation of 5-bromo and 5-iodeoxyuridine into the deoxyribonucleic acid of human cells and its effects on radiation sensitivity. J. Exp. Med. 112:509-531; 1960.
2. 2. Phillips, T. L.; Bodell, W. J.; Uhl, V.; Ross, G. Y.; Rasmussen, J.; Mitchell, J. B. Correlation of exposure time, concentration and incorporation of IdUrd in V-79 cells with radiation exposure. Int. J. Radiat. Oncol. Biol. Phys. 16:1251-1255; 1989.
3. 3. Levin, V. A.; Prados, M. D.; Wara, W. M.; Davis, R. L.; Gutin, P. H.; Phillips, T. L.; Lamborn, K.; Wilson, C. B. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int. J. Radiat. Oncol. Biol. Phys. 32:75-83; 1995.
4. 4. Phillips, T. L.; Levin, V. A.; Ahn, D. K.; Gutin, P. H.; Davis, R. L.; Wilson, C. B.; Prados, M. D.; Wara, W. M.; Flam, M. S. Evaluation of bromodeoxyuridine in glioblastoma multiforme: A Northern California Cancer Center phase II study. Int. J. Radiat. Oncol. Biol. Phys. 21:709-714; 1991.
5. 5. Chang, C. H.; Horton, J.; Schoenfeld, D. L.; Salazar, O.; Perez-Tamayo, R.; Kramer, S.; Weinstein, A.; Nelson, J. S.; Tsukada, Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997-1007; 1983.
6. 6. Nelson, D. F.; Diener-West, M.; Weinstein, A. S.; Schoenfeld, D.; Nelson, J. S.; Sause, W. T.; Chang, C. H.; Goodman, R.; Carabell, S. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: Final report of an RTOG study. Int. J. Radiat. Oncol. Biol. Phys. 12:1793-1800; 1986.
7. 7. Werner-Wasik, M.; Scott, C. B.; Nelson, D. F.; Gaspar, L. E.; Murray, K. J.; Fishbach, J. A.; Nelson, J. S.; Weinstein, A. S.; Curran, W. J., Jr. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant glioma: RTOG 83-02. Cancer 77:1535-1543; 1996.
8. 8. Davis, R. L. Grading of gliomas. In: Fields, W. S., ed. Primary brain tumors. A review of histologic classification. New York: Springer; 1989:150-158.
9. 9. Kleihues, P.; Berger, P. C.; Scheithauer, B. W. Histologic typing of tumors of the central nervous system. Berlin: Springer Verlag; 1993.
10. 10. Barker, F. G., II; Davis, R. L.; Chang, S. M.; Prados, M. D. Necrosis as a prognostic factor in glioblastoma multiforme. Cancer 77:1161-1166; 1996.
11. 11. Nelson, D. F.; Nelson, J. S.; Davis, D. R.; Chang, C. H.; Griffin, T. W.; Pajak, T. F. Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J. Neurooncology 3:99-103; 1985.
12. 12. Prentice, R. L.; Marek, P. A qualitative discrepancy between censored data rank tests. Biometrics 35:861-867; 1979.
13. 13. Peduzzi, P.; Concato, J.; Feinstein, A. R.; Holford, T. R. Importance of events per independent variable in proportional hazards regression analysis: II. Accuracy and precision of regression estimates. J. Clin. Epidemiol. 48:1503-1510; 1995.
14. 14. Curran, W. J., Jr.; Scott, C. B.; Horton, J.; Nelson, J. S.; Weinstein, A. S.; Fishbach, A. J.; Chang, C. H.; Rotman, M.; Asbell, S. O.; Krisch, R. E.; Nelson, D. F. Recursive partitioning analysis of prognostic groups in three radiation therapy oncology malignant glioma trials. J. Natl. Cancer Inst. 85:704-710; 1993.
15. 15. Urtasun, R. C.; Cosmatos, D.; DelRowe, J.; Kinsella, T. J.; Lester, S.; Wasserman, T.; Fulton, D. S. Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: A comparison of short versus long intravenous dose schedules (RTOG 86-12). Int. J. Radiat. Oncol. Biol. Phys. 27:207-214; 1993.
16. 16. Urtasun, R. C.; Kinsella, T. J.; Farnan, N.; DelRowe, J. D.; Lester, S. G.; Fulton, D. S. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated prymidines: Final report of RTOG 86-12, Phase I-II study. Int. J. Radiat. Oncol. Biol. Phys. 36:1163-1167; 1996.
17. 17. Sullivan, F. J.; Herscher, L. L.; Cook, J. A.; Smith, J.; Steinberb, S. M.; Epstein, A. H.; Oldfield, E. H.; Goffman, T. E.; Kinsella, T. J.; Mitchell, J. B.; Glatstein, E. National Cancer Institute study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 30: 583-590; 1994.
18. 18. Scott C. B.; Nelson, J. S.; Farnan, N. C.; Curran, W. J.; Murray, K. J.; Fishbach, A. J.; Gaspar, L. E.; Nelson, D. F. Central pathology review in clinical trials for patients with malignant glioma. Cancer 76:307-313; 1995.